NAYA Biosciences Inc
NASDAQ:NAYA

Watchlist Manager
NAYA Biosciences Inc Logo
NAYA Biosciences Inc
NASDAQ:NAYA
Watchlist
Price: 2.74 USD 17.09% Market Closed
Market Cap: 21.9m USD

Balance Sheet

Balance Sheet Decomposition
NAYA Biosciences Inc

Current Assets 2m
Cash & Short-Term Investments 471.6k
Receivables 257.1k
Other Current Assets 1.2m
Non-Current Assets 15.1m
Long-Term Investments 2.9m
PP&E 2.8m
Intangibles 9.4m

Balance Sheet
NAYA Biosciences Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
0
0
0
0
0
1
10
6
0
0
Cash
0
0
0
0
0
1
10
6
0
0
Total Receivables
0
0
0
0
0
0
0
0
0
0
Accounts Receivables
0
0
0
0
0
0
0
0
0
0
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
0
0
0
0
0
0
0
0
0
0
Other Current Assets
0
0
0
0
0
0
0
0
0
1
Total Current Assets
0
1
0
0
1
2
11
6
1
1
PP&E Net
0
0
0
0
0
0
0
3
2
7
PP&E Gross
0
0
0
0
0
0
0
3
2
7
Accumulated Depreciation
0
0
0
0
0
0
0
0
0
0
Intangible Assets
0
0
0
0
0
0
0
0
0
4
Goodwill
0
0
0
0
0
0
0
0
0
6
Long-Term Investments
0
0
0
0
0
0
0
1
1
3
Other Long-Term Assets
0
0
0
0
0
0
0
0
0
0
Other Assets
0
0
0
0
0
0
0
0
0
6
Total Assets
0
N/A
1
+427%
0
-50%
0
-7%
1
+189%
2
+131%
11
+508%
10
-4%
4
-61%
21
+409%
Liabilities
Accounts Payable
1
1
1
1
1
0
0
0
1
2
Accrued Liabilities
3
3
4
4
3
0
1
1
1
1
Short-Term Debt
1
0
0
0
0
0
0
0
1
1
Current Portion of Long-Term Debt
0
0
0
0
0
0
1
0
0
1
Other Current Liabilities
0
0
0
0
0
1
1
0
0
3
Total Current Liabilities
4
4
5
5
4
2
2
1
3
8
Long-Term Debt
0
0
0
0
0
0
0
0
0
1
Deferred Income Tax
0
0
0
0
0
0
0
0
0
0
Other Liabilities
0
0
0
0
0
4
3
2
2
11
Total Liabilities
4
N/A
4
-3%
5
+13%
5
+7%
4
-33%
6
+57%
5
-6%
3
-39%
5
+61%
20
+294%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
6
Retained Earnings
11
16
18
19
22
24
32
39
50
58
Additional Paid In Capital
6
12
13
14
19
20
38
46
49
53
Total Equity
4
N/A
4
+14%
5
-23%
5
-8%
3
+45%
4
-36%
6
N/A
7
+27%
1
N/A
1
N/A
Total Liabilities & Equity
0
N/A
1
+427%
0
-50%
0
-7%
1
+189%
2
+131%
11
+508%
10
-4%
4
-61%
21
+409%
Shares Outstanding
Common Shares Outstanding
0
0
0
0
0
0
0
1
1
2